Continuing Education Courses

Sunday, June 23 (AM)

CE1 (Sunday AM) 8:00 AM–12:00 Noon

• Data Interpretation, Visualization, and Statistics for Nonclinical Toxicity Studies

  Co-Chairs: Michael Logan, DVM, PhD, DACVP, AbbVie; and Susan G. Emeigh Hart, VMD, PhD, DACVP, DABT, ERT, Boehringer Ingelheim Pharmaceuticals

CE2 (Sunday AM) 8:00 AM–12:00 Noon

• Medical Device Safety Assessment: The Frontiers of Safety Assessment Pathology

  Co-Chairs: Maureen T. O’Brien, DVM, MS, DACVP, Charles River Laboratories; and Serge D. Rousselle, DVM, DACVP, Alizee Pathology

---

Sunday, June 23 (PM)

CE3 (Sunday PM) 1:30 PM–5:30 PM

• Cardiac Effects Commonly Encountered in Drug Development: Mechanisms and Clinical Relevance
  (sponsored by American College of Toxicology)

  Co-Chairs: Matthew M. Abernathy, PhD, DSP, Eli Lilly & Company; and Elizabeth A. Hausner, DVM, PhD, DABT, DABVT, US FDA

CE4 (Sunday PM) 1:30 PM–5:30 PM

• Otic Toxicologic Pathology

  Co-Chairs: Kenneth A. Schafer, DVM, PhD, DACVP, Vet Path Services, Inc.; and Bradley L. Njaa, BSc (Hons), DVM, MVSc, DACVP, Kansas State University

Continuing Education Chair:
Gopakumar Gopalakrishnan, DVM, MS, DABT, DACVP, Supernus Pharmaceuticals

Continuing Education Co-Chair:
Kate Hammerman, VMD, PhD, DACVP, Pfizer